DEVELOPMENT AND VALIDATION OF PATIENT INFORMATION LEAFLET FOR HEART ATTACK PATIENTS
Objective: To prepare a validated heart attack patient information leaflet and to educate and promote the patient knowledge regarding the disease, lifestyle modification, and medication.
Methods: The patient information leaflet was prepared by referring to the various literature. The content of the leaflet was validated by ensuring the quality information for patientâ€™s method. Baker able leaflet design has been applied to develop the layout and design of the PILS and readability by Flesch readability score.
Results: The mean validity score by EQIP method achieved for the leaflet was 84.9%. Flesch readability score is 72.4. Scoring for the leafletâ€™s layout and design criteria based on baker able leaflet design method was 24. The overall knowledge assessment means score was statistically significant with *P value 0.000.
Conclusion: The validated heart attack PILs found to be effective in patients self management.
2. WHO.Preventing Chronic diseases: A vital investment; 2005. Available from: http://www.who.int/chp/chronic_disease_report/en/. [Last accessed on 05 Feb 2016].
3. Charvet-Berard AI, Chopard P. Measuring quality of patient information documents with an expanded EQIP scale. Patient Education Counseling 2008;70:407â€“11.
4. Uday Venkat Mateti, Anantha Naik Nagappa. Preparation, validation and user-testing of pictogram-based patient information leaflets for hemodialysis patients. Saudi Pharm J 2015;23:621â€“5.
5. Raymol Thomas Roy. Preparation and readability assessment of patient information leaflet for diabetic foot ulcers. Journal of social health and diabetes 2013;1:79-81.
6. E Vigneshwaran, Y Padmanabha Reddy, N Devanna. Enhancing quality of life and medication adherence through patient education and counseling among HIV/AIDS patients in resource limited settingsâ€“pre and post interventional pilot trial. Br J Pharm Res 2013;3:485-95.
7. Gibbs S, Waters WE, George CF. Benefits of prescription information leaflets. Part 2. Br J Clin Pharmacol 1989;28:345â€“51.
8. ASHP guidelines on pharmacist-conducted patient education and counseling. Am J Health-Syst Pharm 1997;54:431â€“4.
9. Hill J, Bird H. The development and evaluation of a drug information leaflet for patients with rheumatoid arthritis. Rheumatology 2003;42:66-70.
10. Motlabur Rahman MD, Sattar Sarker MA. Level of knowledge about coronary artery disease is poor among bangladeshi hospitalized patients following acute coronary syndrome. J Med 2013;14:119-22.
11. Abdelmoneim Awad, Hala Al-Nafisi. Public knowledge of cardiovascular disease and its risk factors in Kuwait; a cross-sectional survey. BMC Public Health 2014;14:1131.`
12. Baker S. Who can read consumer product information? Aust J Hosp Pharm 1997;27:126â€“31.
13. Barbara Riegel, Sharon McKinley. Psychometric evaluation of acute coronary syndrome [ACS] response index. Res Nursing Health 2007;30:584-94.
14. Adepu R, Nagavi BG. Patient information leaflets design and readability. Pharm Rev 2003;2:135â€“43.